<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>On the basis of previous work showing that <z:chebi fb="5" ids="47916">flavonoids</z:chebi> structurally related to <z:chebi fb="0" ids="16243">quercetin</z:chebi> are neuroprotective for cells in culture, this work was directed towards determining if several <z:chebi fb="5" ids="47916">flavonoids</z:chebi> (<z:chebi fb="0" ids="16243">quercetin</z:chebi>, <z:chebi fb="0" ids="42567">fisetin</z:chebi> and <z:chebi fb="0" ids="23053">catechin</z:chebi>) could acutely and by an intraperitoneal (IP) route reach significant cerebral concentrations and either prevent or facilitate recovery from a brain lesion induced by focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in rats </plain></SENT>
<SENT sid="1" pm="."><plain>Aqueous and liposomal preparations of <z:chebi fb="0" ids="16243">quercetin</z:chebi>, <z:chebi fb="0" ids="42567">fisetin</z:chebi> and <z:chebi fb="0" ids="23053">catechin</z:chebi> were administered IP in a single dose and assessed in the brain by HPLC at 30 min, 1 h, 2 h and 4 h </plain></SENT>
<SENT sid="2" pm="."><plain>Ischemic damage from focal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> was assessed spectrophotometrically with 2,3,5,-triphenylltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> (TTC) </plain></SENT>
<SENT sid="3" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume was assessed by an image analysis system following perfusion with TTC </plain></SENT>
<SENT sid="4" pm="."><plain>The status of the cerebral tissue was evaluated by <z:chebi fb="1" ids="51686">hematoxylin</z:chebi>-eosin </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="5" ids="47916">Flavonoids</z:chebi> administered in aqueous preparations were undetected in the brain </plain></SENT>
<SENT sid="6" pm="."><plain>Cerebral concentrations of <z:chebi fb="0" ids="23053">catechin</z:chebi> (10.5 ng/g), <z:chebi fb="0" ids="42567">fisetin</z:chebi> (8.23 ng/g) and <z:chebi fb="0" ids="16243">quercetin</z:chebi> (509 ng/g) were detected in the brain only after IP injection of the liposomal preparations </plain></SENT>
<SENT sid="7" pm="."><plain>Spectrophotometric analysis of brain tissue with the TTC-technique showed that liposomal <z:chebi fb="0" ids="16243">quercetin</z:chebi> reduced ischemic damage and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume after permanent occlusion of the middle cerebral artery (ischemic: 41.3 mm3 vs liposomal <z:chebi fb="0" ids="16243">quercetin</z:chebi>: 17 mm3) </plain></SENT>
<SENT sid="8" pm="."><plain>In liposomal <z:chebi fb="0" ids="16243">quercetin</z:chebi>-treated animals there was also recovery of the cytoarchitecture in ischemic areas of striatum and cortex </plain></SENT>
<SENT sid="9" pm="."><plain>Although a liposomal preparation of <z:chebi fb="0" ids="42567">fisetin</z:chebi> had similar effects, <z:chebi fb="0" ids="23053">catechin</z:chebi> failed to protect brain tissue </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, early administration of liposomal preparations of <z:chebi fb="0" ids="16243">quercetin</z:chebi> and structurally related <z:chebi fb="5" ids="47916">flavonoids</z:chebi> are beneficial and neuroprotective in experimental focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>